Larvol Delta - A-Phase-I-Study-of-JSB462-Luxdegalutamide-in-Japanese-Patients-With-Metastatic-Prostate-Cancer

luxdegalutamide (ARV-766) - Novartis

http://clinicaltrials.gov/ct2/show/NCT07174063

Jun 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next